Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

The winter virus season comes with sniffles and coughs accompanying holiday tunes. For anyone who doesn’t want to climb out of bed to get tested, see a doctor, or get medication for a ...

At-home COVID-19 tests were an important part of preventing viral spread during the pandemic, and now there are FDA-approved tests that screen for COVID, Influenza A, and Influenza B in one go at ...

If you're wondering if your at-home COVID-19 test kits are still OK to use, we've got good news. Even if your box says it's expired, there's a chance the shelf life has been extended. In one ...

Blood samples collected at a dozen time points during the first 100 days after vaccination took stock of all the genes, proteins and antibodies at work during each person’s immune response.

Currently, blood test readings are based on one-size-fits ... think of clinical tests as purely diagnostic. For example, a COVID-19 or a pregnancy test comes back as either positive or negative ...

Currently, blood test readings are based on one-size-fits ... think of clinical tests as purely diagnostic. For example, a COVID-19 or a pregnancy test comes back as either positive or negative ...

Researchers at Stanford University discover tell-tale signs in the blood that indicate how quickly a person’s antibody ...

Ohio-based Aerpio has started a phase 2 trial of its razuprotafib drug, given as a subcutaneous injection three times a day, to hospitalised subjects with moderate to severe COVID-19, to see if it ...